Search - tctmd.com

Displaying 901 - 920 of 1063

Sort: Relevancy | Date

News Daily News

State Registry Shows Radial PCI Rare but Beneficial

January 14, 2013

News Daily News

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Yael L. Maxwell

January 13, 2013

News Daily News

European Registries Show Solid Gains in TAVR Outcomes

Caitlin E. Cox

January 13, 2013

News Industry News

Abbott Initiates Clinical Trial of Absorb™ in the United States

January 07, 2013

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Caitlin E. Cox

January 02, 2013

News Daily News

Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI

Yael L. Maxwell

December 19, 2012

News Industry News

St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization

December 17, 2012

News Daily News

Cell Therapy Shows Promise for Critical Limb Ischemia

December 03, 2012

News Daily News

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

L.A. McKeown

November 28, 2012

News Daily News

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

L.A. McKeown

November 18, 2012

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Daily News

Procedural, Spontaneous MI Carry Different Prognostic Weights

November 08, 2012

News Conference News AHA 2012

RIME: Mitral Annuloplasty Plus CABG Improves Functional Capacity, Regurgitation

Jason Kahn

November 06, 2012

News Conference News AHA 2012

Cell Therapy Trials Show Mixed Results at AHA 2012

November 05, 2012

News Conference News TCT 2012

AIDA-STEMI Substudy Confirms Original Findings

October 26, 2012

News Conference News TCT 2012

Future Looks Bright for Stem Cell-Based Myocardial Therapy

October 26, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

News Industry News

Study Confirms that Intracoronary and Intravenous Use of ABCIXIMAB During Angioplasty Yield Similar Results

October 25, 2012

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

News Industry News

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

October 24, 2012

Advertisement

State Registry Shows Radial PCI Rare but Beneficial

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

European Registries Show Solid Gains in TAVR Outcomes

Abbott Initiates Clinical Trial of Absorb™ in the United States

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI

St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization

Cell Therapy Shows Promise for Critical Limb Ischemia

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Procedural, Spontaneous MI Carry Different Prognostic Weights

RIME: Mitral Annuloplasty Plus CABG Improves Functional Capacity, Regurgitation

Cell Therapy Trials Show Mixed Results at AHA 2012

AIDA-STEMI Substudy Confirms Original Findings

Future Looks Bright for Stem Cell-Based Myocardial Therapy

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Study Confirms that Intracoronary and Intravenous Use of ABCIXIMAB During Angioplasty Yield Similar Results

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content